Panel Discussion: Is Prioritizing Combination Therapy Over Monotherapy the Most Promising Avenue for Overcoming Heterogeneity?

Time: 4:30 pm
day: Conference Day 1


  • Understand the shortfalls of key therapy types with regard to targeting tumor heterogeneity and how combination therapies can be used to strategically overcome these
  • Combine drug treatments with radiotherapy or tumor treating fields
  • Are combination therapies considered ‘too risky’ from a regulatory standpoint?
  • Understand how the regulatory framework can best support the approval of combination therapies